李艳, 祝维泽, 李后开. 中药复方和活性化合物调节肠道菌群治疗非酒精性脂肪肝的研究进展J. 药学学报, 2022, 57(12): 3451-3464. DOI: 10.16438/j.0513-4870.2022-0605
引用本文: 李艳, 祝维泽, 李后开. 中药复方和活性化合物调节肠道菌群治疗非酒精性脂肪肝的研究进展J. 药学学报, 2022, 57(12): 3451-3464. DOI: 10.16438/j.0513-4870.2022-0605
LI Yan, ZHU Wei-ze, LI Hou-kai. Research progress of traditional Chinese medicine formulas and active compounds in the treatment of non-alcoholic fatty liver disease by regulating gut microbiotaJ. Acta Pharmaceutica Sinica, 2022, 57(12): 3451-3464. DOI: 10.16438/j.0513-4870.2022-0605
Citation: LI Yan, ZHU Wei-ze, LI Hou-kai. Research progress of traditional Chinese medicine formulas and active compounds in the treatment of non-alcoholic fatty liver disease by regulating gut microbiotaJ. Acta Pharmaceutica Sinica, 2022, 57(12): 3451-3464. DOI: 10.16438/j.0513-4870.2022-0605

中药复方和活性化合物调节肠道菌群治疗非酒精性脂肪肝的研究进展

Research progress of traditional Chinese medicine formulas and active compounds in the treatment of non-alcoholic fatty liver disease by regulating gut microbiota

  • 摘要: 非酒精性脂肪肝(non-alcoholic fatty liver disease, NAFLD) 是最常见的慢性肝病。然而, 由于其发病机制复杂, 目前尚无正式获批的治疗药物, 寻找安全、有效的抗NAFLD药物迫在眉睫。在现代医学中, NAFLD治疗以降脂药物作为主要治疗手段, 但是, 化学药物的临床疗效也十分有限, 且存在明显的不良反应。中药以其多途径、多靶点、不良反应少等特点在NAFLD的治疗中越来越受到关注。近年来, 大量研究证据表明肠道菌群失衡在NAFLD的发生发展中起重要作用。本综述系统汇总了近些年涉及到中药复方和中药活性化合物通过调节肠道菌群治疗NAFLD的研究情况, 为进一步探索NAFLD的发病机制和运用中医药治疗NAFLD的理念提供新的参考方向。

     

    Abstract: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases. However, due to its complex pathogenesis, there are no officially approved drugs for NAFLD treatment currently. Therefore, it is extremely urgent to find safe and effective anti-NAFLD drugs. Nowadays, lipid-lowering drugs are the main option for NAFLD therapy, but the clinical efficacy of chemical drugs is also very limited, as well as the frequent side effects or adverse reactions. Traditional Chinese medicine (TCM) has attracted more and more attention in the treatment of NAFLD due to its unique advantages through multiple targets and pathways with few side effects. In recent years, numerous studies have demonstrated that the imbalance of gut microbiota plays an important role in the occurrence and development of NAFLD. This review systematically summarizes the experimental and clinical evidences of TCM active compounds and TCM prescription involved in the regulation of intestinal flora in the treatment of NAFLD in recent years, so as to provide a reference for further exploring the pathogenesis of NAFLD and exploring TCM treatment methods.

     

/

返回文章
返回